explore -WSS

explore

author：comprehensive 2025-09-09 04:38:56 - browse：2635

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Lung cancer is America's deadliest cancer. Yet so few get screened

WSS

Covid's long

Lung cancer is America's deadliest cancer. Yet so few get screened

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Novo acquires Inversago for up to $1 billion

The boys, now 6, who are gene therapy’s ‘edge case’ problem

New definition of a human embryo proposed amid rapid advances

hotspot

explore

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Continuity nursing helped my family in our darkest PICU moments

Liz Cheney makes 1st public comment since Trump's election interference indictments

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Target recalls 2.2 million additional candles due to laceration, burn hazards

Continuity nursing helped my family in our darkest PICU moments

Faced with fears of OxyContin misuse, sales reps touted its safety

After affirmative action ruling, medical educators look to 'holistic review'

Trump's false claims about Georgia's 2020 election long debunked

hotspot

Genentech weighs delaying cancer therapy after drug pricing law

Maui funeral service workers on devastation of fires: 'I'm in shock'

Congress must give Medicare recipients genetic counseling access

Majority of Americans think Trump's Ga. election interference case is serious: POLL

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

The history of OxyContin, told through Purdue Pharma documents

leisure time

focus

Wikipedia

hotspot